European Medicines Agency (EMA) is organising its second Awareness Session, in London, on 8-9 March 2018. The full title of the event is “Second international awareness session for international regulators, academia and non-governmental organisations” and it is aimed to provide insight into the EU regulatory system and the role of the EMA, into scientific aspects of EMA’s work and its interaction with scientific experts.
Many topics will be addressed during the session: Advance Therapies Medication (ATMPs), Clinical trials in the EU, EMA support to innovation, dealing with specific populations and types of products (with a focus on paediatric and orphan medicines), Good Practices, the role of experts and benefit-risk evaluation, patient safety and pharmacovigilance, international cooperation. The event will also provide the participants with networking opportunities with academics, NGOs staff and regulators from and outside the EU.
The event will be broadcasted live and EMA will publish further materials after the event.